AbbVie Cash vs Long Term Debt Analysis

ABBV Stock

USD 171.73 3.97 2.37%

AbbVie financial indicator trend analysis is way more than just evaluating AbbVie Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AbbVie Inc is a good investment. Please check the relationship between AbbVie Cash and its Long Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Cash vs Long Term Debt

Cash vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AbbVie Inc Cash account and Long Term Debt. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between AbbVie's Cash and Long Term Debt is 0.53. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of AbbVie Inc, assuming nothing else is changed. The correlation between historical values of AbbVie's Cash and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of AbbVie Inc are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Cash i.e., AbbVie's Cash and Long Term Debt go up and down completely randomly.

Correlation Coefficient

0.53

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Cash

Cash refers to the most liquid asset of AbbVie Inc, which is listed under current asset account on AbbVie Inc balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from AbbVie customers. The amounts must be unrestricted with restricted cash listed in a different AbbVie account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Long Term Debt

Long-term debt is a debt that AbbVie Inc has held for over one year. Long-term debt appears on AbbVie Inc balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on AbbVie Inc balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most indicators from AbbVie's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AbbVie Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Sales General And Administrative To Revenue is likely to climb to 0.28 in 2024, whereas Selling General Administrative is likely to drop slightly above 7.8 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	38.8B	40.6B	45.5B	25.2B
Total Revenue	56.2B	58.1B	54.3B	33.8B

Gross Profit Total Revenue

AbbVie fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Property Plant Equipment	Long Term Debt
Common Stock Shares Outstanding		0.6	0.81	0.78	0.73	0.71	0.71	0.53	0.8	-0.29	0.67	0.81	-0.31	0.74	0.66	-0.37	0.44	0.69	0.65	0.74	0.5	0.89	0.07	0.66	0.7	0.36
Total Assets	0.6		0.81	0.85	0.35	0.9	0.97	0.96	0.81	0.31	0.98	0.84	0.29	0.93	0.99	-0.4	0.97	0.95	0.66	0.36	0.99	0.75	0.66	0.97	0.95	0.94
Other Current Liab	0.81	0.81		0.98	0.33	0.96	0.84	0.72	0.98	0.2	0.79	0.97	0.18	0.87	0.83	-0.41	0.75	0.86	0.6	0.37	0.79	0.96	0.53	0.76	0.84	0.71
Total Current Liabilities	0.78	0.85	0.98		0.3	0.97	0.88	0.79	0.97	0.22	0.84	0.96	0.2	0.87	0.86	-0.44	0.8	0.87	0.62	0.34	0.84	0.93	0.55	0.81	0.87	0.76
Total Stockholder Equity	0.73	0.35	0.33	0.3		0.26	0.48	0.29	0.26	-0.52	0.46	0.42	-0.55	0.46	0.4	-0.26	0.14	0.4	0.61	0.98	0.19	0.47	-0.24	0.48	0.47	0.07
Other Liab	0.71	0.9	0.96	0.97	0.26		0.87	0.84	0.96	0.29	0.87	0.93	0.27	0.86	0.9	-0.4	0.87	0.88	0.66	0.28	0.89	0.88	0.62	0.85	0.86	0.84
Property Plant And Equipment Net	0.71	0.97	0.84	0.88	0.48	0.87		0.92	0.81	0.15	0.98	0.89	0.13	0.96	0.98	-0.44	0.89	0.96	0.68	0.52	0.93	0.81	0.53	0.96	0.99	0.84
Net Debt	0.53	0.96	0.72	0.79	0.29	0.84	0.92		0.74	0.19	0.97	0.77	0.17	0.84	0.96	-0.28	0.95	0.87	0.57	0.31	0.95	0.64	0.52	0.98	0.89	0.93
Accounts Payable	0.8	0.81	0.98	0.97	0.26	0.96	0.81	0.74		0.22	0.79	0.93	0.2	0.85	0.83	-0.43	0.76	0.86	0.58	0.3	0.8	0.94	0.54	0.76	0.81	0.73
Cash	-0.29	0.31	0.2	0.22	-0.52	0.29	0.15	0.19	0.22		0.13	0.17	1.0	0.17	0.19	-0.28	0.46	0.22	-0.05	-0.51	0.42	0.1	0.91	0.1	0.16	0.53
Non Current Assets Total	0.67	0.98	0.79	0.84	0.46	0.87	0.98	0.97	0.79	0.13		0.84	0.11	0.92	0.99	-0.36	0.93	0.94	0.69	0.47	0.95	0.75	0.5	1.0	0.96	0.88
Other Assets	0.81	0.84	0.97	0.96	0.42	0.93	0.89	0.77	0.93	0.17	0.84		0.15	0.88	0.85	-0.46	0.77	0.88	0.59	0.48	0.81	0.92	0.51	0.82	0.88	0.74
Cash And Short Term Investments	-0.31	0.29	0.18	0.2	-0.55	0.27	0.13	0.17	0.2	1.0	0.11	0.15		0.15	0.17	-0.22	0.45	0.2	-0.07	-0.54	0.4	0.08	0.9	0.08	0.13	0.51
Net Receivables	0.74	0.93	0.87	0.87	0.46	0.86	0.96	0.84	0.85	0.17	0.92	0.88	0.15		0.95	-0.39	0.85	0.98	0.66	0.48	0.89	0.87	0.56	0.9	0.97	0.78
Good Will	0.66	0.99	0.83	0.86	0.4	0.9	0.98	0.96	0.83	0.19	0.99	0.85	0.17	0.95		-0.38	0.94	0.97	0.68	0.42	0.97	0.78	0.57	0.98	0.97	0.89
Short Term Investments	-0.37	-0.4	-0.41	-0.44	-0.26	-0.4	-0.44	-0.28	-0.43	-0.28	-0.36	-0.46	-0.22	-0.39	-0.38		-0.35	-0.42	-0.29	-0.29	-0.37	-0.41	-0.36	-0.35	-0.43	-0.33
Non Current Liabilities Total	0.44	0.97	0.75	0.8	0.14	0.87	0.89	0.95	0.76	0.46	0.93	0.77	0.45	0.85	0.94	-0.35		0.89	0.55	0.16	0.99	0.65	0.75	0.92	0.87	0.99
Inventory	0.69	0.95	0.86	0.87	0.4	0.88	0.96	0.87	0.86	0.22	0.94	0.88	0.2	0.98	0.97	-0.42	0.89		0.64	0.44	0.93	0.82	0.59	0.91	0.98	0.83
Other Current Assets	0.65	0.66	0.6	0.62	0.61	0.66	0.68	0.57	0.58	-0.05	0.69	0.59	-0.07	0.66	0.68	-0.29	0.55	0.64		0.57	0.59	0.65	0.29	0.68	0.69	0.46
Other Stockholder Equity	0.74	0.36	0.37	0.34	0.98	0.28	0.52	0.31	0.3	-0.51	0.47	0.48	-0.54	0.48	0.42	-0.29	0.16	0.44	0.57		0.21	0.49	-0.22	0.49	0.52	0.08
Total Liab	0.5	0.99	0.79	0.84	0.19	0.89	0.93	0.95	0.8	0.42	0.95	0.81	0.4	0.89	0.97	-0.37	0.99	0.93	0.59	0.21		0.7	0.73	0.93	0.92	0.97
Property Plant And Equipment Gross	0.89	0.75	0.96	0.93	0.47	0.88	0.81	0.64	0.94	0.1	0.75	0.92	0.08	0.87	0.78	-0.41	0.65	0.82	0.65	0.49	0.7		0.45	0.72	0.81	0.59
Total Current Assets	0.07	0.66	0.53	0.55	-0.24	0.62	0.53	0.52	0.54	0.91	0.5	0.51	0.9	0.56	0.57	-0.36	0.75	0.59	0.29	-0.22	0.73	0.45		0.47	0.54	0.77
Intangible Assets	0.66	0.97	0.76	0.81	0.48	0.85	0.96	0.98	0.76	0.1	1.0	0.82	0.08	0.9	0.98	-0.35	0.92	0.91	0.68	0.49	0.93	0.72	0.47		0.94	0.88
Property Plant Equipment	0.7	0.95	0.84	0.87	0.47	0.86	0.99	0.89	0.81	0.16	0.96	0.88	0.13	0.97	0.97	-0.43	0.87	0.98	0.69	0.52	0.92	0.81	0.54	0.94		0.82
Long Term Debt	0.36	0.94	0.71	0.76	0.07	0.84	0.84	0.93	0.73	0.53	0.88	0.74	0.51	0.78	0.89	-0.33	0.99	0.83	0.46	0.08	0.97	0.59	0.77	0.88	0.82

Click cells to compare fundamentals

AbbVie Account Relationship Matchups

AbbVie fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	1.5B	1.7B	1.8B	1.8B	1.8B	1.8B
Total Assets	89.1B	150.6B	146.5B	138.8B	134.7B	81.2B
Other Current Liab	10.4B	17.9B	19.8B	22.5B	27.0B	28.3B
Total Current Liabilities	15.6B	28.7B	35.2B	29.5B	37.8B	39.7B
Total Stockholder Equity	(8.2B)	13.1B	15.4B	17.3B	10.4B	7.1B
Other Liab	18.5B	30.4B	31.0B	31.7B	36.5B	38.3B
Property Plant And Equipment Net	3.0B	5.2B	5.1B	4.9B	5.0B	3.6B
Net Debt	26.8B	77.6B	66.9B	54.1B	46.6B	32.2B
Accounts Payable	1.5B	2.3B	2.9B	2.9B	3.7B	3.9B
Cash	39.9B	8.4B	9.7B	9.2B	12.8B	10.5B
Non Current Assets Total	39.6B	126.4B	118.6B	110.3B	101.7B	57.7B
Other Assets	1.9B	5.1B	4.1B	4.8B	5.6B	5.8B
Cash And Short Term Investments	39.9B	8.5B	9.8B	9.2B	12.8B	11.0B
Net Receivables	5.4B	8.8B	10.0B	11.3B	11.2B	6.8B
Good Will	15.6B	33.1B	32.4B	32.2B	32.3B	18.6B
Short Term Investments	0.0	30M	84M	28M	2M	1.9M
Liabilities And Stockholders Equity	89.1B	150.6B	146.5B	138.8B	134.7B	81.2B
Non Current Liabilities Total	81.7B	108.8B	95.9B	92.0B	86.5B	55.5B
Inventory	1.8B	3.3B	3.1B	3.6B	4.1B	2.2B
Other Stockholder Equity	(9.3B)	15.1B	15.2B	14.7B	13.6B	7.1B
Total Liab	97.3B	137.5B	131.1B	121.5B	124.3B	74.1B
Property Plant And Equipment Gross	3.0B	5.2B	10.7B	11.0B	11.6B	12.2B
Total Current Assets	49.5B	24.2B	27.9B	28.5B	33.0B	23.5B
Accumulated Other Comprehensive Income	(3.6B)	(3.1B)	(2.9B)	(2.2B)	(2.3B)	(2.4B)
Intangible Assets	18.6B	82.9B	76.0B	67.4B	55.6B	32.2B
Property Plant Equipment	3.0B	5.2B	5.1B	4.9B	5.7B	3.4B
Long Term Debt	63.0B	77.6B	64.2B	59.1B	52.2B	41.2B
Short Long Term Debt Total	66.7B	86.1B	76.7B	63.3B	59.4B	49.8B
Non Currrent Assets Other	1.2B	4.9B	4.9B	5.6B	8.5B	8.9B
Short Term Debt	3.8B	8.5B	12.5B	4.1B	7.2B	5.2B
Net Tangible Assets	(42.4B)	(102.9B)	(96.2B)	(82.3B)	(74.1B)	(77.8B)
Retained Earnings	4.7B	1.1B	3.1B	4.8B	(1B)	(950M)
Retained Earnings Total Equity	4.7B	1.1B	3.1B	4.8B	5.5B	3.4B
Long Term Debt Total	63.0B	77.6B	64.2B	59.1B	68.0B	50.1B
Capital Surpluse	15.2B	17.4B	18.3B	19.2B	22.1B	15.8B
Additional Paid In Capital	15.2B	17.4B	18.3B	19.2B	20.2B	15.0B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC